Search Share Prices
AZN Shares - Two of AstraZeneca’s key cancer drugs win speedy approvals in Japan
Two of AstraZeneca PLC’s (LON:AZN) key cancer drugs have been approved by Japanese regulators, less than six months after getting the green light in Western markets. Japan has traditionally been slow to adopt new medicines, but today’s approvals are ...
AstraZeneca share price: Group wins oncology drug approvals in Japan
AstraZeneca’s (LON:AZN) oncology treatments Imfinzi and Lynparza have won approvals in Japan, the blue-chip pharmco has said. The news comes after the company and partner Merck & Co posted upbeat results from a late-stage trial for first-line use of ...
Is dividend growth ahead for AstraZeneca plc, National Grid plc, BP plc and Berkeley Group Holdings PLC?
Dividend growth can have a significant impact on share price performance from my experience, which is why I’m focusing on the prospects of AstraZeneca plc (LON:AZN) (AZN.L), National Grid plc (LON:NG) (NG.L), BP plc (LON:BP) (BP.L) and Berkeley Group ...
AstraZeneca PLC (LON:AZN) “Buy” Rating Has Just Been Reiterated by Citigroup
Among 14 analysts covering Astrazeneca (LON:AZN), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. Astrazeneca has GBX 7800 highest and GBX 62 lowest target. GBX 5891.86’s average target is 12.78% above currents GBX 5224 stock price.
Analyst at Citigroup Keeps AstraZeneca PLC (LON:AZN)Stock Rating as a ‘Buy’
Among 14 analysts covering Astrazeneca (LON:AZN), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. Astrazeneca has GBX 7800 highest and GBX 62 lowest target. GBX 5891.86’s average target is 12.78% above currents GBX 5224 stock price.